ZA957414B - Oxazoloquinolinone derivatives their preparation and their therapeutic application - Google Patents

Oxazoloquinolinone derivatives their preparation and their therapeutic application

Info

Publication number
ZA957414B
ZA957414B ZA957414A ZA957414A ZA957414B ZA 957414 B ZA957414 B ZA 957414B ZA 957414 A ZA957414 A ZA 957414A ZA 957414 A ZA957414 A ZA 957414A ZA 957414 B ZA957414 B ZA 957414B
Authority
ZA
South Africa
Prior art keywords
preparation
therapeutic application
oxazoloquinolinone
derivatives
oxazoloquinolinone derivatives
Prior art date
Application number
ZA957414A
Other languages
English (en)
Inventor
Samir Jegham
Jean Jacques Koenig
Frederic Puech
Philippe Burnier
Lydia Zard
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA957414B publication Critical patent/ZA957414B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Quinoline Compounds (AREA)
ZA957414A 1994-09-05 1995-09-04 Oxazoloquinolinone derivatives their preparation and their therapeutic application ZA957414B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9410600A FR2724171B1 (fr) 1994-09-05 1994-09-05 Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ZA957414B true ZA957414B (en) 1996-04-15

Family

ID=9466686

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA957414A ZA957414B (en) 1994-09-05 1995-09-04 Oxazoloquinolinone derivatives their preparation and their therapeutic application

Country Status (28)

Country Link
US (1) US5641785A (xx)
EP (1) EP0699680B1 (xx)
JP (1) JP4225585B2 (xx)
KR (1) KR100392523B1 (xx)
CN (1) CN1055472C (xx)
AT (1) ATE190311T1 (xx)
AU (1) AU687591B2 (xx)
CA (1) CA2157427C (xx)
CZ (1) CZ286128B6 (xx)
DE (1) DE69515402T2 (xx)
DK (1) DK0699680T3 (xx)
ES (1) ES2145886T3 (xx)
FI (1) FI110945B (xx)
FR (1) FR2724171B1 (xx)
GR (1) GR3033554T3 (xx)
HK (1) HK1013652A1 (xx)
HU (1) HU218587B (xx)
IL (1) IL115276A (xx)
NO (1) NO306617B1 (xx)
NZ (1) NZ272920A (xx)
PL (1) PL184412B1 (xx)
PT (1) PT699680E (xx)
RU (1) RU2141482C1 (xx)
SI (1) SI0699680T1 (xx)
SK (1) SK281867B6 (xx)
TW (1) TW356467B (xx)
UA (1) UA41916C2 (xx)
ZA (1) ZA957414B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
WO2005090309A1 (en) * 2004-03-12 2005-09-29 Wyeth 1,2-dihydroquinoline derivatives and method for using the same to treat hiv infection
AU2008226649B2 (en) * 2007-03-09 2013-08-01 Sanofi Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
RU2366430C2 (ru) 2007-05-23 2009-09-10 Виктор Иванович Рощин Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
CN105949120B (zh) 2016-05-27 2018-07-24 广东工业大学 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624861B1 (fr) * 1987-12-21 1990-06-01 Delalande Sa Carbamates tricycliques, leur procede de preparation et leur application en therapeutique
ES2013391A6 (es) * 1989-02-08 1990-05-01 Consejo Superior Investigacion Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles.
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法

Also Published As

Publication number Publication date
NO953458L (no) 1996-03-06
IL115276A (en) 1998-12-06
EP0699680B1 (fr) 2000-03-08
AU3041595A (en) 1996-03-21
US5641785A (en) 1997-06-24
JPH0899881A (ja) 1996-04-16
SI0699680T1 (en) 2000-10-31
NO953458D0 (no) 1995-09-04
PL310273A1 (en) 1996-03-18
NO306617B1 (no) 1999-11-29
GR3033554T3 (en) 2000-09-29
PT699680E (pt) 2000-08-31
HU9502578D0 (en) 1995-11-28
PL184412B1 (pl) 2002-10-31
TW356467B (en) 1999-04-21
CZ286128B6 (cs) 2000-01-12
CN1128763A (zh) 1996-08-14
UA41916C2 (uk) 2001-10-15
FR2724171B1 (fr) 1997-01-03
FI954141A (fi) 1996-03-06
HU218587B (hu) 2000-10-28
FI954141A0 (fi) 1995-09-04
EP0699680A1 (fr) 1996-03-06
SK281867B6 (sk) 2001-08-06
FR2724171A1 (fr) 1996-03-08
JP4225585B2 (ja) 2009-02-18
DE69515402D1 (de) 2000-04-13
IL115276A0 (en) 1996-01-19
AU687591B2 (en) 1998-02-26
HK1013652A1 (en) 1999-09-03
HUT73435A (en) 1996-07-29
ES2145886T3 (es) 2000-07-16
RU2141482C1 (ru) 1999-11-20
CN1055472C (zh) 2000-08-16
FI110945B (fi) 2003-04-30
CA2157427A1 (en) 1996-03-06
CA2157427C (en) 2010-06-01
CZ226295A3 (en) 1996-03-13
KR100392523B1 (ko) 2003-11-12
NZ272920A (en) 1998-03-25
DE69515402T2 (de) 2000-10-19
SK108995A3 (en) 1996-06-05
ATE190311T1 (de) 2000-03-15
KR960010648A (ko) 1996-04-20
DK0699680T3 (da) 2000-08-21

Similar Documents

Publication Publication Date Title
FI945703A (fi) 3,4,4-trisybstituoitujen piperidinyyli-N-alkyylikarboksylaattien ja välituotteiden valmistus
AU4523797A (en) Atherosclerosis treatment
FI930977A (fi) Taxanderivat, deras framstaellning och onkologiska anvaendning
ES2112029T3 (es) Nuevos filtros solares, composiciones cosmeticas fotoprotectoras que los contienen y utilizaciones.
ATE126221T1 (de) Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung.
IL115276A0 (en) Oxazoloquinolinone derivatives their preparation and their therapeutic application
FI925848A (fi) Tizolidinfoereningar, som innehaoller en kinogrupp, deras framstaellning och terapeutiska anvaendningar
CA2251003A1 (fr) Nouveaux composes derives de n-aryl 2-hydroxy alkylamides
DE69033342D1 (de) Etoposidanaloge
AU4585096A (en) New tricyclic derivatives, their preparation, their use for the preparation of optically active or racemic colchicine and thiocolchicine and analogues or derivatives and intermediates
NZ536524A (en) Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
FR2716198B1 (fr) Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
ATE153340T1 (de) Cyathane derivate und diese enthaltende nervenwachstumsfaktor produktion stimulatoren und antimikrobielle mittel
ZA93292B (en) Alkyl derivatives of trazodone
FI952203A0 (fi) Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi
FI912269A (fi) 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa.
NO994107L (no) Preparater for behandling eller forhindring av prostatakreft
RS50791B (sr) Farmaceutske kombinacije zasnovane na derivatima piridoindolona
DE3865521D1 (de) 4-methyl-4-phenyl-1-pentanale, deren herstellung und verwendung als riechstoffe.
UA19097A (uk) D-1-ФЕHІЛ-2-МЕТИЛАМІHОПРОПАHОЛА 1-5,6,7-ТРИОКСИФЛАВОH-7-0-beta-D-ГЛЮКУРОHИДАТ, ЩО МАЄ ОКИСЛЮВАЛЬHУ ДІЮ ТА РОЗШИРЮЄ СУДИHИ
IT1245737B (it) Trialchilsilil tetrafluoroetanfosfonati e procedimento per la loro preparazione